SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Compaq -- Ignore unavailable to you. Want to Upgrade?


To: rupert1 who wrote (61622)5/19/1999 5:09:00 AM
From: rupert1  Read Replies (1) | Respond to of 97611
 
Notice how DELL is trying to be another COMPAQ! The final sentence of this piece shows how it is trying to do an Alta Vista.

--

Dell's Net Rises, but Analysts Focus
On Firm's Eroding Profit Margins
By GARY MCWILLIAMS
Staff Reporter of THE WALL STREET JOURNAL

Dell Computer Corp.'s quarterly profit rose 42%, in line with Wall Street expectations, but its shares fell as investors focused on the company's eroding profit margins.

Dell fell to $41.125 in after-hours trading from its Nasdaq Stock Market closing price of $44.0625, up 81.25 cents. The results for Dell's fiscal-first quarter ended April 30 were released after the close of regular trading Tuesday.

The Round Rock, Texas, personal-computer maker said it earned $434 million, or 16 cents a diluted share, compared with $305 million, or 11 cents a share, a year earlier. Revenue jumped 41% to $5.54 billion, from $3.92 billion.

Continues to Outpace Rivals

Dell's chief executive, Michael S. Dell, said the company continues to outpace its rivals, with sales of network servers and consumer PCs leading its revenue gains. Server and workstation sales rose 97% over year-earlier levels, up from the 80% growth rate in the fourth quarter.

Company Profile: Dell Computer

In addition, a decision to accelerate sales gains through lower pricing worked as planned, Mr. Dell said. The company said it jumped over International Business Machines Corp., Armonk, N.Y., to become the second-largest seller of PCs in the U.S. during the period.

"In the fourth quarter, we felt we weren't as aggressive as we could be," Mr. Dell said. "We got more aggressive."

Analysts, however, said a decline in gross margins was larger than they expected and indicated a difficult pricing environment. Gross margins fell nearly a full percentage point to 21.5% of sales, from 22.4% in the fourth quarter.

"It's heading into a much more difficult sales environment," said Ashok Kumar, an analyst at U.S. Bancorp Piper Jaffray. He now projects sales for the current quarter to rise just 34% to $5.81 billion, from a previous estimate of $5.9 billion.

'Not Like the Old Days'

"It's not like the old days when Dell's margins expanded as Compaq's blew up," said analyst Don Young at PaineWebber Inc., who recently lowered his recommendation on the stock to "neutral" from "attractive." "This would be far worse if Dell didn't have a spectacular performance in servers," he said.


The average selling price of a Dell PC fell 7% to $2,300, from $2,475 a year earlier. The price decline reflects lower parts costs and the first period in which Dell has sold PCs for less than $1,000.

"You can't look at a 42% profit increase as terribly disappointing," said William C. Conroy, an analyst Sanders Morris Munday. However, he added, the margin erosion "was a little bit heavier than we were looking for."

Mr. Dell said the company continued to struggle in Germany, where fierce pricing has slowed sales gains. Its European sales rose 29%, well below a 45% gain in its Americas regions and a 48% gain in its Asian sales.

"We're certainly working on reaching our full potential in Europe," Mr. Dell said. "There's work to be done there."

Strong Demand for Network Servers

The chief reason that margins didn't decline further was that demand was strong for Dell's network servers during the quarter, according to market researchers. "Dell regained the momentum in servers it had coming into the fourth quarter last year," said Kimball Brown, chief analyst at researcher Dataquest, a Gartner Group Inc. unit.

In the fourth quarter ended Jan. 29, Dell's revenue gains slowed to a 38% year-over-year increase as a result of server-sales losses to rivals IBM and Compaq Computer Corp., Mr. Brown recalled. "Neither of those two was as hungry in the first quarter," he said.

In the U.S., the world's largest PC market, Dell's PC-unit sales are within striking distance of market leader Compaq, Houston. Market researcher International Data Corp. estimates the direct seller shipped 1.45 million PCs in the first three months of the year, just 132,000 PCs fewer than Compaq did. "Dell has just been extremely strong," said IDC research manager Roger Kay.

The company generated $1 billion in cash from operations during the quarter, pushing its cash and marketable securities to $4 billion, from $2.4 billion a year earlier. In addition to using cash for stock repurchases, Dell recently launched an effort to take minority stakes in companies that may aid its revenue gains. It has discussed making investments in drkoop.com Inc., an online consumer health-care information provider, and NaviSite Inc., an Internet-hosting company. No deals have yet been reached, the company said



To: rupert1 who wrote (61622)5/19/1999 6:12:00 AM
From: rupert1  Read Replies (1) | Respond to of 97611
 
--------------------------------------------------------------------------------


DJ Compaq's Rosen Says Biotech Needs More People, Software
By PAULA L. STEPANKOWSKY
Dow Jones Newswires

SEATTLE -- The convergence of biology and computing is making scientific research faster, but there is a shortage of people and software needed to keep up with the pace, said Ben Rosen, chairman of Compaq Computer Corp. (CPQ) at the Bio '99 conference here Tuesday.

Rosen replaced former Compaq CEO Eckhard Pfeiffer on the program after Compaq's board dismissed Pfeiffer last month. Rosen declined press interviews following his prepared remarks given at a meeting that has drawn more than 5000 people from around the world.

But Rosen follows the biotech industry closely and said that the frontiers of biology and computing are converging in ways that are revolutionizing biological research, genetics, drug discovery and medicine.

"Today, it is increasingly difficult to separate the advances in biotechnology from advances in high-performance computing," Rosen said. "In fact, some leading scientists believe that high-end computing is the future of biology and medicine."

Rosen said as scientists look increasingly toward genetic solutions to the treatment and cure of disease, more computing power is needed to sequence the entire human genome and provide answers to these biological questions.

"Biology is becoming an information science," he said. "It will take increasingly powerful computers and software to gather, store, analyze, model and distribute that information."

The biggest challenge for biotechnology, Rosen said, will be to turn that information into knowledge that will help scientists understand how genes work and enable the development of new and more effective drugs.

Sees Internet As Growing Force In Biotech
Rosen said that the biotech industry is hampered by the fact that there is a severe shortage of biological scientists with strong computing skills. While there are specialists in each field, there aren't many knowledgeable in both fields.

"One scientist told me that biologists with a strong knowledge of computing now command salaries two to three times what they can make strictly as a biologist," Rosen said. "That's a clear indication that the demand far outstrips the supply."

He also said most software available for use by the biotech industry comes from academic sources and isn't specifically tailored for the "bioinformatics" industry.

"The challenge is to find a viable business model for companies that are basically taking academic software and passing it through to the commercial world," Rosen said.

While the software industry may be lagging behind, Rosen said the Internet is assuming increasing importance in biotech research. The Internet, working with specially designed search software, makes it possible for scientists to access daily updates from the Human Genome Project, a project launched in 1990 to sequence all human genes, and other sources.

"This brings an immediacy to science that wasn't there before," Rosen said.

Speaking to an audience that grouses openly about how Internet companies have diverted investment away from biotech, Rosen said companies disregard the Internet at their peril.

"The fact remains that any business - from a bookseller to a biotech company - that is not factoring the Internet into its plans will quickly find itself at a competitive disadvantage," Rosen said. "The Internet is not just changing business - it's changing science and the ways that we disseminate scientific knowledge."

Compaq To Support Growing Biotech Needs
Rosen said Compaq has realized the need for more support from the computer industry for the biotech industry.

He said the company recently hired Dr. Nathan Goodman to establish a bioinformatics solution center in Massachusetts for the company. He said the company's 64-bit Alpha microprocessor is being used by a number of companies to speed up their research.

One of them is Celera Genomics, run by well-known biologist Dr. J. Craig Venter, who most recently was director of the Institute for Genomic Research. Celera plans to decode the entire human genome by the end of 2001 and has connected 1,200 Alpha processors to help in the work.

Celera plans to make the information it gathers available to subscribers using the Internet and other electronic commerce technology, Rosen said.

"Celera believes its customer base will expand from agriculture, pharmaceutical and biotech companies initially to academics, physicians and individuals," Rosen said.

- Paula L. Stepankowsky; 360-636-2008